Schedule 13G ownership disclosure

OWC Pharmaceutical Research Corp.

Security class unavailable · CUSIP: 67109N108

Event date: 2016-06-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-109393
Form type
SC 13G
Filer
OWC Pharmaceutical Research Corp.
CIK
CIK 1431934
Filed
Jun 23, 2016
Reporting period
Jun 11, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub